4564.T
Price:
$21
Market Cap:
$7.11B
OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as...[Read more]
Industry
Biotechnology
IPO Date
2005-09-29
Stock Exchange
JPX
Ticker
4564.T
According to OncoTherapy Science, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.06. This represents a change of 7.83% compared to the average of 3.76 of the last 4 quarters.
The mean historical Current Ratio of OncoTherapy Science, Inc. over the last ten years is 14.91. The current 4.06 Current Ratio has changed 2.62% with respect to the historical average. Over the past ten years (40 quarters), 4564.T's Current Ratio was at its highest in in the September 2015 quarter at 42.31. The Current Ratio was at its lowest in in the March 2024 quarter at 2.27.
Average
14.91
Median
15.07
Minimum
2.27
Maximum
35.79
Discovering the peaks and valleys of OncoTherapy Science, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 48.35%
Maximum Annual Current Ratio = 35.79
Minimum Annual Increase = -73.77%
Minimum Annual Current Ratio = 2.27
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.37 | 48.35% |
| 2024 | 2.27 | -2.59% |
| 2023 | 2.33 | -45.70% |
| 2022 | 4.30 | -73.77% |
| 2021 | 16.39 | -18.41% |
| 2020 | 20.08 | 46.09% |
| 2019 | 13.75 | -40.17% |
| 2018 | 22.98 | -17.39% |
| 2017 | 27.81 | -22.29% |
| 2016 | 35.79 | -25.46% |
The current Current Ratio of OncoTherapy Science, Inc. (4564.T) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
2.66
5-year avg
5.73
10-year avg
14.91
OncoTherapy Science, Inc.’s Current Ratio is less than K Pharma,Inc. (19.41), less than BrightPath Biotherapeutics Co., Ltd. (12.43), less than ADR120S, Inc. (5.44), less than Noile-Immune Biotech Inc. (69.34), less than TMS Co., Ltd. (26.11), greater than Linical Co., Ltd. (1.55), less than Chiome Bioscience Inc. (4.72), less than MedRx Co., Ltd (28.01), greater than Kohjin Bio Co., Ltd. (1.83), less than Delta-Fly Pharma, Inc. (5.48),
| Company | Current Ratio | Market cap |
|---|---|---|
| 19.41 | $7.43B | |
| 12.43 | $4.63B | |
| 5.44 | $7.44B | |
| 69.34 | $6.97B | |
| 26.11 | $6.10B | |
| 1.55 | $6.82B | |
| 4.72 | $7.55B | |
| 28.01 | $6.53B | |
| 1.83 | $7.96B | |
| 5.48 | $5.91B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoTherapy Science, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OncoTherapy Science, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is OncoTherapy Science, Inc.'s Current Ratio?
How is the Current Ratio calculated for OncoTherapy Science, Inc. (4564.T)?
What is the highest Current Ratio for OncoTherapy Science, Inc. (4564.T)?
What is the 3-year average Current Ratio for OncoTherapy Science, Inc. (4564.T)?
What is the 5-year average Current Ratio for OncoTherapy Science, Inc. (4564.T)?
How does the current Current Ratio for OncoTherapy Science, Inc. (4564.T) compare to its historical average?